Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Von Hippel-Lindau syndrome

H P Neumann1, C J Lips, Y E Hsia

  • 1Department of Medicine, Albert-Ludwigs-University, Freiburg, Germany.

Brain Pathology (Zurich, Switzerland)
|April 1, 1995
PubMed
Summary

Genetic analysis of the von Hippel-Lindau (VHL) gene identified germline mutations in 75% of families. Specific VHL mutations correlate with distinct disease patterns, aiding carrier status determination.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Who Is at Risk for Psychological Distress in Genetic Testing Programs for Hereditary Cancer Disorders?

Journal of genetic counseling·2015
Same author

The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance.

Oncogene·2006
Same author

Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer.

Journal of medical genetics·2006
Same author

Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.

Journal of medical genetics·2005
Same author

Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines.

Journal of internal medicine·2004
Same author

[From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].

Nederlands tijdschrift voor geneeskunde·2002

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • The von Hippel-Lindau (VHL) gene, cloned in 1993, is a tumor suppressor gene implicated in hereditary cancer syndromes.
  • VHL disease is characterized by the development of multiple tumors and cysts in various organs.

Purpose of the Study:

  • To investigate the spectrum of mutations in the VHL gene.
  • To establish genotype-phenotype correlations in VHL disease.
  • To improve diagnostic capabilities and carrier status determination for VHL families.

Main Methods:

  • Comprehensive mutation screening of the VHL gene in affected families.
  • Detailed clinical evaluation and phenotyping of patients.
  • Analysis of genotype-phenotype relationships.

Main Results:

  • Germline mutations in the VHL gene were identified in approximately 75% of VHL families studied.
  • A variety of mutations, including point mutations, deletions, and rearrangements, were detected.
  • Specific VHL mutations were associated with distinct clinical manifestations and tumor patterns, such as pheochromocytoma without renal cancer linked to point mutations.

Conclusions:

  • Molecular genetic analysis of the VHL gene is crucial for diagnosing VHL disease and identifying carriers.
  • Understanding genotype-phenotype correlations enhances the prediction of disease manifestations and progression.
  • These findings contribute to a better understanding of the VHL gene's role in tumorigenesis and cancer susceptibility.

Related Experiment Videos